Angle-fixated Anterior Chamber Phakic Intraocular Lens for Myopia of -7 to -19 Diopters

Phakic posterior chamber lens implantation in children with high myopia

PURPOSE

To evaluate the anatomical and functional results after implantation of a phakic posterior chamber lens (implantable contact lens [ICL]) to correct high myopia with amblyopia in pediatric patients in whom conventional treatments had failed.

SETTING

Department of Ophthalmology, Purpan Hospital, University of Toulouse, France.

METHODS

An ICL was implanted in 5 eyes with amblyopic high myopia in 4 children aged 3 to 16 years. Mean preoperative spherical equivalent refraction was -12.8 diopters (D) (range -8.0 to -18.0 D) and best spectacle-corrected visual acuity (BSCVA) was counting fingers to 20/200. Mean follow-up was 11.8 months (range 4 to 21 months).

RESULTS

Postoperatively, the ICLs appeared to be well tolerated, with no inflammatory reactions, stable intraocular pressure, and good positioning in all eyes. Predictability was +0.5 D (range -0.5 to +2.0 D) and BSCVA improved, with a gain of 3 or more Snellen lines with recovery of binocular vision in 2 cases and orthotropia in 3 patients. All parents reported an improvement in their children's quality of life.

CONCLUSION

This preliminary study indicates that ICL implantation is a safe surgical procedure to correct amblyopia resulting from high myopia in children when conventional amblyopia treatments have failed. Longer follow-up of more patients is needed.

Endophthalmitis after phakic intraocular lens implantation to correct high myopia

A 36-year-old woman had uneventful implantation of an angle-supported anterior chamber phakic intraocular lens (IOL) to correct high myopia. On the first postoperative day, she developed infectious endophthalmitis likely associated with intraoperative contamination. Group B beta-hemolytic Streptococcus endophthalmitis was confirmed by microbiologic studies. To our knowledge, this is the first documented case of infectious endophthalmitis after anterior chamber phakic IOL implantation to correct high myopia.

High incidence of cataract formation after implantation of a silicone posterior chamber lens in phakic, highly myopic eyes

OBJECTIVE

To assess the effectiveness and safety of implantation of a negative, silicone, posterior chamber intraocular lens (IOL) in the ciliary sulcus of phakic, highly myopic eyes.

DESIGN

Noncomparative consecutive interventional series.

PARTICIPANTS

Eighteen eyes of 10 patients suffering from high-degree myopia (spherical equivalent < -10 diopters) undergoing implantation of a Fyodorov 094M-1 IOL by the same surgeon (P.H.B.) were evaluated.

INTERVENTION

A standard surgical technique was used in all patients under peribulbar anesthesia. The IOL was implanted in the ciliary sulcus immediately in front of the natural lens under protection of a viscoelastic substance (Healon) through a 3.5-mm temporal or nasal clear-corneal tunnel. No sutures were necessary in any case. A peripheral iridectomy was performed intraoperatively in 14 eyes, whereas 4 additional eyes received a yttrium-aluminum-garnet peripheral iridectomy after surgery. At the end of surgery, gentamicin and dexamethasone were given both topically and subconjunctivally.

MAIN OUTCOME MEASURES

Visual acuity and refraction were measured before surgery, as well as 1 day, 3 months, 6 months, and 2 years after surgery. Postoperative complications were recorded.

RESULTS

Best-corrected visual acuity remained unchanged (1 eye) or improved (6 eyes by 1, 5 eyes by 2, and 2 eyes by 3 Snellen lines, respectively) in 14 of 17 eyes, whereas 3 eyes experienced a decrease in best-corrected visual acuity by 1 Snellen line. Postoperative refraction approached the desired slight undercorrection at all times of examination. Cataract formation of the anterior subcapsular (8 eyes) or nuclear (only 1 eye) type was observed in overall 9 (52.9%) of 17 eyes. When considering only the patients with a follow-up of 2 years, the incidence of cataract formation was 81.9% (9 of 11 eyes).

CONCLUSIONS

The high incidence of cataract formation should discourage the implantation of the type of IOL used in this study in phakic eyes to correct high-degree myopia.

Posterior Chamber Phakic Intraocular Lens for Hyperopia of +4 to +11 Diopters

PURPOSE

To examine the efficacy, predictability, stability, and safety of posterior chamber phakic intraocular lens (IOL) implantation in eyes with high hyperopia.

METHODS

We analyzed the results of 24 eyes that received a posterior chamber hydrogel-collagen plate phakic IOL (Staar Collamer Implantable Contact Lens, ICL) for the correction of hyperopia with the goal of emmetropia. Mean follow-up was 8.4 months (range, 1 to 18 mo).

RESULTS

The mean preoperative spherical equivalent refraction was +6.51 +/- 2.08 D (range, +3.75 to +10.50 D). Mean postoperative spherical equivalent refraction at last examination was -0.39 +/- 1.29 D (range, +1.25 to -3.88 D), with 79% (19 eyes) within +/-1.00 D and 58% (14 eyes) within +/-0.50 D of emmetropia. Postoperative uncorrected visual acuity at last examination was 20/20 or better in 8% (two eyes) and 20/40 or better in 63% (15 eyes). A gain of two or more lines of spectacle-corrected visual acuity was seen in two eyes (8%) at last examination. One eye (4%) lost two or more lines of spectacle-corrected visual acuity due to progressive neovascular glaucoma initiated by early postoperative pupillary block.

CONCLUSION

Posterior chamber phakic IOL implantation with the Staar Collamer plate lens is an effective method for correcting high hyperopia. Large, patent iridotomies are important in hyperopic eyes to lower the risk of postoperative pupillary block. Improved phakic IOL power calculation formulas will refine predictability of refractive outcome.

Posterior Chamber Phakic Intraocular Lens for Myopia of -8 to -19 Diopters

PURPOSE

To examine the efficacy, predictability, stability, and safety of posterior chamber phakic intraocular lens (IOL) implantation in patients with extreme myopia.

METHODS

We analyzed the results of 124 eyes that received a posterior chamber hydrogel collagen plate phakic IOL (Staar Collamer Implantable Contact Lens, ICL) for the correction of their myopia. The target postoperative spherical equivalent refraction was emmetropia. Mean follow-up was 11 months (range 1 to 36 mo).

RESULTS

The mean preoperative spherical equivalent refraction was -13.38 +/- 2.23 D (range, -8.50 to -18.63 D). Mean postoperative spherical equivalent refraction at last examination was -0.78 +/- 0.87 D (range, +1.63 to -3.50 D), with 69% (86 eyes) within +/-1.00 D and 44% (55 eyes) within +/-0.50 D of emmetropia. The refraction remained stable with a statistically insignificant change (p > 0.05 at each interval) during follow-up. A gain of two or more lines of spectacle-corrected visual acuity was seen in 36% (45 eyes) at last examination. One eye (0.8%) lost two or more lines of spectacle-corrected visual acuity from a retinal detachment.

CONCLUSION

Posterior chamber phakic IOL implantation with the Staar Collamer plate lens is an effective and safe method for reducing or correcting myopia between -8 and -19 D. Gains in spectacle-corrected visual acuity were common, and results suggested good refractive stability. Improvements in phakic IOL power calculation formulas are needed to improve the predictability of refractive outcome.